Just closed: BioVentures Investors raises $29m

View the latest closings

BioVentures Investors has raised $29 million for its BioVentures Investors IV, according to a SEC filing. The Wellesley-headquartered firm began fundraising in 2015 with a $100 million target.

Its previous fund raised $51 million in 2007.

The fund will target venture capital opportunities in biotech/life science sectors in North America.